Oricef 1 gm/vial (IM Injection)
1 gm vial: ৳ 320.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
Ceftriaxone is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic that kills bacteria by interfering with the synthesis of the bacterial cell wall. It has a long plasma elimination half-life, is not metabolized in the body, and is highly protein bound (95%).
Dosage
- Adult:
- Usual dose: 1 to 2 gm by intravenous or intramuscular administration once a day
- Maximum dose: 4 gm/day
- Infants and Children (01 month or older):
- Usual dose: 50 to 75 mg/kg intravenous or intramuscular administration once a day
- Maximum dose: 2 gm/day
- Duration of therapy: Continue for more than 2 days after signs and symptoms of infection have disappeared. Usual duration is 4 to 14 days; in complicated infections, longer therapy may be required.
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections
- Injection should be administered over 2-4 minutes, by Intramuscular or Intravenous injection or by tubing infusion over a period of 30 minutes at concentration between 10 mg/mL and 40 mg/mL
- Patient tolerance test should be checked by administration of a test dose
Interaction
No drug interactions have been reported.
Contraindications
Ceftriaxone should not be given to patients with a history of hypersensitivity to cephalosporin antibiotics.
Side Effects
- Gastro-intestinal effects including diarrhea, nausea and vomiting, stomatitis and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness
- Local phlebitis occurs rarely following intravenous administration but can be minimized by slow injections
Pregnancy & Lactation
- Safety in human pregnancy has not been established
- Caution should be exercised when Ceftriaxone is administered to a lactating mother
Precautions & Warnings
- Anaphylactic shock requires immediate countermeasures such as intravenous epinephrine followed by a glucocorticoid
- Shadows suggesting sludge have been detected by sonograms of the gallbladder in rare cases
- Blood picture should be checked at regular intervals during prolonged treatment
Use in Special Populations
Oricef must not be given to neonates if the neonate is premature and newborn (up to 28 days of age).
Overdose Effects
There is no specific antidote. Treatment of overdosage should be symptomatic.
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Vial store in a cool, dry place (below 30° C), away from light & moisture. Keep out of the reach of children.
Related Brands
- Oricef 500 mg/vial (IM Injection) - healthcare-pharmaceuticals-ltd
- Oricef 250 mg/vial (IM Injection) - healthcare-pharmaceuticals-ltd
- Odatrix 2 gm/vial (IV Injection) - unimed-unihealth-pharmaceuticals-ltd
- Odatrix 1 gm/vial (IV Injection) - unimed-unihealth-pharmaceuticals-ltd
- Odatrix 500 mg/vial (IM Injection) - unimed-unihealth-pharmaceuticals-ltd